About this trial
Short-term comparison of clinical application effects of Astra OsseoSpeed EV short implants and conventional implants for maxillary sinus elevation
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients aged over 18 years old with at least one area of the posterior dental arch having insufficient alveolar bone height (3-6 mm)
Patients are in good health and have no major systemic diseases such as diabetes or cardiovascular diseases, and no maxillary sinus lesions
They are willing to undergo implant restoration treatment and can complete at least 3-year follow-up.
Disqualifiers
horizontal bone deficiency alveolar ridges,bone defects caused by tumor resection
excessive tobacco use (more than 10 cigarettes per day)
severe liver and kidney diseases
history of radiotherapy and chemotherapy in the head and neck region
Trial design
Sequential
Treatments tested in this trial
short implants (L=6.3mm)
DeviceShort-term clinical outcome of Astra OsseoSpeed EV short implants (L=6.3mm) for transcrestal sinus floor elevation
short implants (L=8mm)
Procedure/SurgeryShort-term clinical outcome of Astra OsseoSpeed EV short implants (L=8mm) for transcrestal sinus floor elevation
conventional implants (L=9mm)
Deviceconventional implants (L=9mm) in the posterior maxillary region for dental restoration
Treatment groups
Trial outcomes
Primary outcomes
Various complications
the rate of Implant survival, swelling, pain, etc.
Secondary outcomes
marginal bone resorption
Measure the changes in the bone height around the implant
Other outcomes
Patient satisfaction
Very satisfied, satisfied, dissatisfied, the rate of dissatisfaction, etc.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Linhu Wang
Lead sponsor
Wuhan Central Hospital
Sponsor institution
Dentsply Sirona Implants and Consumables
Collaborator
This trial is not recruiting at the moment. You can still explore other options: